Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early tirofiban treatment in acute ischemic non-large vessel occlusive stroke (observational registry)
ChiCTR2100042184Phase 4Recruiting
- Sponsor
- Xinqiao Hospital
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of tirofiban in brain infarction (2 arms), sponsored by Xinqiao Hospital. Primary endpoints: mRS at 90 days and Incidence of symptomatic intracranial hemorrhage within 48 hours. Started Jan 2021; status: recruiting.
02
Drugs
tirofiban
03
Conditions
brain infarction
Beyond the preview
Go deeper on ChiCTR2100042184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042184.